These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34230966)

  • 61. Travellers' diarrhoea.
    Ericsson CD
    Int J Antimicrob Agents; 2003 Feb; 21(2):116-24. PubMed ID: 12615374
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A double-blind, placebo-controlled, randomized human study assessing the capacity of a novel galacto-oligosaccharide mixture in reducing travellers' diarrhoea.
    Drakoularakou A; Tzortzis G; Rastall RA; Gibson GR
    Eur J Clin Nutr; 2010 Feb; 64(2):146-52. PubMed ID: 19756029
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diarrhoea in a large prospective cohort of European travellers to resource-limited destinations.
    Pitzurra R; Steffen R; Tschopp A; Mutsch M
    BMC Infect Dis; 2010 Aug; 10():231. PubMed ID: 20684768
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epidemiology and self-treatment of travelers' diarrhea in a large, prospective cohort of department of defense beneficiaries.
    Lalani T; Maguire JD; Grant EM; Fraser J; Ganesan A; Johnson MD; Deiss RG; Riddle MS; Burgess T; Tribble DR;
    J Travel Med; 2015; 22(3):152-60. PubMed ID: 25483360
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Incidence and risk factors of diarrhoea in Dutch travellers: consequences for priorities in pre-travel health advice.
    Cobelens FG; Leentvaar-Kuijpers A; Kleijnen J; Coutinho RA
    Trop Med Int Health; 1998 Nov; 3(11):896-903. PubMed ID: 9855403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sodium butyrate and short chain fatty acids in prevention of travellers' diarrhoea: a randomized prospective study.
    Krokowicz L; Kaczmarek BF; Krokowicz P; Stojcev Z; Mackiewicz J; Walkowiak J; Drews M; Banasiewicz T
    Travel Med Infect Dis; 2014; 12(2):183-8. PubMed ID: 24063909
    [TBL] [Abstract][Full Text] [Related]  

  • 67. What's new in enteric infectious diseases at home and abroad.
    DuPont HL
    Curr Opin Infect Dis; 2005 Oct; 18(5):407-12. PubMed ID: 16148527
    [TBL] [Abstract][Full Text] [Related]  

  • 68. High carriage rates of extended-spectrum beta-lactamase-producing
    Jewoola OO; Bode-Sojobi IO; Ogunsola FT; Okonji PE
    Niger Postgrad Med J; 2020; 27(2):136-142. PubMed ID: 32295946
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intestinal colonization with extended-spectrum beta-lactamase producing Enterobacterales (ESBL-PE) during long distance travel: A cohort study in a German travel clinic (2016-2017).
    Meurs L; Lempp FS; Lippmann N; Trawinski H; Rodloff AC; Eckardt M; Klingeberg A; Eckmanns T; Walter J; Lübbert C;
    Travel Med Infect Dis; 2020; 33():101521. PubMed ID: 31770602
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Review of Guidelines/Guidance from Various Countries Around the World for the Prevention and Management of Travellers' Diarrhoea: A Pharmacist's Perspective.
    Hitch G
    Pharmacy (Basel); 2019 Aug; 7(3):. PubMed ID: 31382691
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.
    Dalhoff A
    Infection; 2012 Jun; 40(3):239-62. PubMed ID: 22460782
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic symptoms persisting after travel-related infections.
    Kuna A; Gajewski M
    Int Marit Health; 2018; 69(3):207-212. PubMed ID: 30270419
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Travellers' diarrhoea: causes, prevention and treatment.
    Lloyd R; Bennett C
    Nurs Stand; 2012 Jun 6-12; 26(40):51-6; quiz 58. PubMed ID: 22848971
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.
    Steffen R; Jiang ZD; Gracias Garcia ML; Araujo P; Stiess M; Nacak T; Greinwald R; DuPont HL
    J Travel Med; 2018 Jan; 25(1):. PubMed ID: 30462260
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extended-spectrum beta-lactamase-producing Escherichia coli in patients with travellers' diarrhoea.
    Tham J; Odenholt I; Walder M; Brolund A; Ahl J; Melander E
    Scand J Infect Dis; 2010 Apr; 42(4):275-80. PubMed ID: 20121649
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of gut microbiota in travel-related acquisition of extended spectrum β-lactamase-producing Enterobacteriaceae.
    Peng Y; Liang S; Poonsuk K; On H; Li SW; Maurin MMP; Chan CH; Chan CL; Sin ZY; Tun HM
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33615366
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update.
    Ruppé E; Andremont A; Armand-Lefèvre L
    Travel Med Infect Dis; 2018; 21():28-35. PubMed ID: 29155322
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children.
    Islam S; Selvarangan R; Kanwar N; McHenry R; Chappell JD; Halasa N; Wikswo ME; Payne DC; Azimi PH; McDonald LC; Gomez-Duarte OG
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):234-240. PubMed ID: 28992133
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effectiveness of rifaximin in prevention of diarrhoea in individuals travelling to south and southeast Asia: a randomised, double-blind, placebo-controlled, phase 3 trial.
    Zanger P; Nurjadi D; Gabor J; Gaile M; Kremsner PG
    Lancet Infect Dis; 2013 Nov; 13(11):946-54. PubMed ID: 24012319
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Travellers' diarrhoea.
    Farthing MJ
    Br J Hosp Med; 1992 Jul 1-28; 48(2):82-92. PubMed ID: 1504706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.